1586. Impact of Dolutegravir-based Regimen on Metabolic Syndrome and its Components in Adults with HIV in Care at Hospital Roosevelt in Guatemala City

BACKGROUND: Integrase inhibitors (INSTI) are associated with weight gain, elevated glucose and lipid changes. Use of the INSTI dolutegravir (DTG) is increasing in Latin America. We assessed the impact of DTG switch on Metabolic Syndrome (MetS) and its components in people with HIV (PWH) in Guatemala...

Descripción completa

Detalles Bibliográficos
Autores principales: Farfán, Alvaro J Mazariegos, Marroquin, Hugo, Ortiz, Dean, Parra-Rodriguez, Luis, Spec, Andrej, Meléndez, Johanna, Pinzón, Rodolfo, Samayoa, Johanna, Mejia-Chew, Carlos, O’Halloran, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677742/
http://dx.doi.org/10.1093/ofid/ofad500.1421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677742/
http://dx.doi.org/10.1093/ofid/ofad500.1421

Ejemplares similares